AU2001236141A1 - Immunoassay and diagnostic reagent for malaria - Google Patents

Immunoassay and diagnostic reagent for malaria

Info

Publication number
AU2001236141A1
AU2001236141A1 AU2001236141A AU3614101A AU2001236141A1 AU 2001236141 A1 AU2001236141 A1 AU 2001236141A1 AU 2001236141 A AU2001236141 A AU 2001236141A AU 3614101 A AU3614101 A AU 3614101A AU 2001236141 A1 AU2001236141 A1 AU 2001236141A1
Authority
AU
Australia
Prior art keywords
malaria
immunoassay
diagnostic reagent
diagnostic
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236141A
Other languages
English (en)
Inventor
Hyung-Cheol Kim
Sang-Ik Lee
Seung-Won Lee
Kook-Jin Lim
Jae-Hoon Oh
Mi-Jin Shon
Seung-Bum Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Corp
Original Assignee
LG Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2000-0007649A external-priority patent/KR100400666B1/ko
Priority claimed from KR20000007650A external-priority patent/KR100482190B1/ko
Priority claimed from KR10-2000-0012172A external-priority patent/KR100373918B1/ko
Priority claimed from KR10-2000-0045806A external-priority patent/KR100427513B1/ko
Application filed by LG Chemical Co Ltd filed Critical LG Chemical Co Ltd
Publication of AU2001236141A1 publication Critical patent/AU2001236141A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445—Plasmodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001236141A 2000-02-17 2001-02-15 Immunoassay and diagnostic reagent for malaria Abandoned AU2001236141A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
KR10-2000-0007649A KR100400666B1 (ko) 2000-02-17 2000-02-17 효모를 이용한 삼일열 말라리아 원충 표면 단백질의제조방법
KR007650 2000-02-17
KR20000007650A KR100482190B1 (ko) 2000-02-17 2000-02-17 대장균을 이용한 삼일열 말라리아 원충의 표면 단백질의 제조방법
KR20000007648 2000-02-17
KR007648 2000-02-17
KR007649 2000-02-17
KR0012172 2000-03-10
KR10-2000-0012172A KR100373918B1 (ko) 2000-02-17 2000-03-10 말라리아의 효소 면역학적 측정방법 및 이에 사용되는진단시약
KR0045806 2000-08-08
KR10-2000-0045806A KR100427513B1 (ko) 2000-02-17 2000-08-08 말라리아 특이 면역글로블린 엠의 검출에 의한 말라리아의면역학적 측정방법, 진단시약 및 진단방법
PCT/KR2001/000229 WO2001061032A1 (en) 2000-02-17 2001-02-15 Immunoassay and diagnostic reagent for malaria

Publications (1)

Publication Number Publication Date
AU2001236141A1 true AU2001236141A1 (en) 2001-08-27

Family

ID=27532341

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236141A Abandoned AU2001236141A1 (en) 2000-02-17 2001-02-15 Immunoassay and diagnostic reagent for malaria

Country Status (9)

Country Link
US (1) US20040132117A1 (es)
EP (1) EP1255852B9 (es)
CN (1) CN1406284A (es)
AR (1) AR027370A1 (es)
AT (1) ATE417124T1 (es)
AU (1) AU2001236141A1 (es)
DE (1) DE60136911D1 (es)
PE (1) PE20011332A1 (es)
WO (1) WO2001061032A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100373918B1 (ko) * 2000-02-17 2003-02-26 주식회사 엘지생명과학 말라리아의 효소 면역학적 측정방법 및 이에 사용되는진단시약
KR100427513B1 (ko) * 2000-02-17 2004-04-30 주식회사 엘지생명과학 말라리아 특이 면역글로블린 엠의 검출에 의한 말라리아의면역학적 측정방법, 진단시약 및 진단방법
DE10161051B4 (de) * 2001-12-12 2005-09-15 Wieland, Heinrich, Prof. Dr. Diagnose der Malaria
KR101035111B1 (ko) * 2004-06-30 2011-05-19 주식회사 엘지생명과학 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단
US20080080302A1 (en) * 2006-09-29 2008-04-03 Fujifilm Corporation Droplet mixing method and apparatus
KR100968848B1 (ko) * 2007-12-13 2010-07-09 주식회사 바이오랜드 삼일열 및 열대열 말라리아 젖산탈수소효소에 특이적인항체 및 이를 포함하는 열대열 말라리아와 삼일열말라리아의 중복 감염 진단 키트
US20130131104A1 (en) * 2010-03-23 2013-05-23 Board Of Trustees Of Michigan State University Histidine rich protein-2 diagnostic test for cerebral malaria
CN102981002B (zh) * 2012-11-29 2014-08-06 同昕生物技术（北京）有限公司 采用标签蛋白人源化嵌合抗体作为阳性对照物的间接免疫检测方法及试剂盒
CN103965313B (zh) * 2013-01-28 2016-04-13 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN103965324B (zh) * 2013-01-29 2016-08-10 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN113406045B (zh) * 2020-03-16 2022-11-04 广州创瑞健康科技有限公司 一种疟原虫检测的荧光染色方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304371A (en) * 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
EP0885012A4 (en) * 1996-01-29 2001-09-05 Univ Georgetown MALARIA VACCINES USING AN MSA1 PEPTIDE
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19723463A1 (de) * 1997-06-04 1998-12-10 Dade Behring Marburg Gmbh Immunchemische Bestimmung von multivalenten Analyten

Also Published As

Publication number Publication date
ATE417124T1 (de) 2008-12-15
US20040132117A1 (en) 2004-07-08
EP1255852A4 (en) 2004-12-29
DE60136911D1 (de) 2009-01-22
AR027370A1 (es) 2003-03-26
PE20011332A1 (es) 2002-01-24
EP1255852B1 (en) 2008-12-10
CN1406284A (zh) 2003-03-26
EP1255852A1 (en) 2002-11-13
WO2001061032A1 (en) 2001-08-23
EP1255852B9 (en) 2009-04-15

Similar Documents

Publication Publication Date Title
AUPR005600A0 (en) Diagnostic assay
AU2001245439A1 (en) Immunochromatographic assay method and apparatus
AU2002251913A1 (en) Hybrid antibodies and uses thereof
AU2002300939A1 (en) Reagents and Methods for Detecting Analytes, and Devices Comprising Reagents for Detecting Analytes
AU2001236780A1 (en) Analyte assays employing universal arrays
AU2002365649A1 (en) Anti-dota antibody
AU2002359392A1 (en) Rapid prion-detection assay
AU2002324881A1 (en) Diagnostic and prognostic tests
AU2001236141A1 (en) Immunoassay and diagnostic reagent for malaria
AU8763098A (en) Immunoassay device
AU2002332088A1 (en) Methods and reagents for improved cell-based assays
AU3717601A (en) Ultrasonic testing
AU4586700A (en) Improved assay and reagents therefor
AU2001232041A1 (en) Improved assay
AU2002221132A1 (en) Novel antibody
AU2001289066A1 (en) Methods and devices for assays using analyte-binding partners
GB0014838D0 (en) An assay
AU5240901A (en) Assay
AU2002350951A1 (en) Assay device and method
AU2002217217A1 (en) Immunoassay device and method
AU4523299A (en) Analyte assay device
AU2002222146A1 (en) Reagents and methods for use inn the detection of analytes
AU2001276499A1 (en) Assay
AU3389501A (en) Assay
AU2001295042A1 (en) Anti-stilbene antibodies